Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. Opportunities Originator pharma companies are developing more and more complex products these days.

Production 130

Production Pharma Companies Clinical Trials FDA 130

Drug Discovery World

MAY 6, 2024

Even before this, however, Amsterdam was established as an important centre for drug development. The company is now investigating a promising gene therapy for Huntingdon’s disease in a Phase I/II trial, with patients already showing signs of preserved neurological function.

Drugs 148

Drugs Science Molecular Biology Clinical Trials 148

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. How AI can streamline drug discovery . When considering which companies to partner with, Big Pharma will look for several green flags.

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. AI and big data are now commonly involved with drug discovery and development.

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Drug Discovery World

MARCH 29, 2023

Antibiotic development According to Politico, the European Medicines Agency is investigating a chronic shortage in antibiotics across Europe, where almost every country is reporting gaps in supplies – 25 out of the 27 EU countries have reported local shortages, the agency’s Chief Medical Officer, Steffen Thirstrup, told a press briefing 6.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Drug Discovery World

OCTOBER 6, 2022

With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. According to McKinsey & Company: “Europe’s complex biotech landscape comprises hundreds of companies, dozens of countries, and multiple paths to innovation and financing… .

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Pharma Companies Marketing 130

Drug Discovery World

OCTOBER 4, 2022

“Recent reports suggest global market value is forecasted to grow to $25-$40 billion before the end of this decade, driven primarily by the introduction of disease-modifying therapies with accompanying biomarkers for early diagnosis, coupled with the demographic rise in the number of patients.” .

Disease 130

Disease Small Molecule Compound Screening Clinical Development 130

Drug Discovery World

JANUARY 24, 2023

In early November 2022, two Alzheimer’s drugs were tested head-to-head in a first-ever virtual clinical trial 3. ” 4,5,6 Asking the right questions Norstella is a newly formed company that aims to guide life sciences companies through drug development so patients can access therapies quicker.

Clinical Trials 242

Clinical Trials Trials Drugs Treatment 242

Drug Discovery World

FEBRUARY 10, 2023

The pharma companies that are based in Sweden, are international ones, and often have a marketing and commercial side but maybe not that drug development side that really brings that key focus area between the development and commercialisation.” Having our process verified at Testa Center is pure risk minimisation.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Drug Discovery World

NOVEMBER 16, 2022

It’s hoped that through this, scientists will be able to better predict how drug molecules perform in the body, leading to expedited drug development and better outcomes for patients. . That means if two pharma companies are trying to grow say a cardiac organoid, they won’t be consistent across the board,” he says. .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Drug Discovery World

AUGUST 5, 2022

Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Why sponsors use external consultants.

Drug Development 130

Drug Development Drugs Pharma Companies International 130

The Pharma Data

OCTOBER 20, 2020

In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. But now they’ll be choosing the therapies themselves. .

Clinical Trials 52

Clinical Trials Pharma Companies Therapies Trials 52

Drug Discovery World

DECEMBER 14, 2023

Paul Smith, CEO at BioAscent, agrees: “Collaboration is central to the continued development of Glasgow as a globally important drug discovery hub. All parties are aware that to do this successfully requires the engagement with experts who understand the practicalities, complexities and pitfalls of industrial drug discovery.

Drugs 190

Drugs Science Research Laboratories 190

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

Drug Discovery World

OCTOBER 25, 2023

MT: What does VeriSIM Life do, and how does this influence drug discovery? JV: Our mission is to solve the translational challenges that every biotech and pharma company faces, and get more novel therapies to patients, faster. MT: Has the company enabled any recent breakthroughs with its technology?

Pharma Companies 279

Pharma Companies Drugs Clinical Trials Drug Development 279

Drug Discovery World

APRIL 19, 2023

Rivka Kreitman , CIO of NeuraLight explores the landscape of therapies for Alzheimer’s and explains why digital biomarkers are key to combatting the disease. But there are still challenges facing the development of therapies for neurodegenerative diseases, and a few emerging technologies can be used to measure the efficacy of such advances.

Therapies 130

Therapies FDA Approval Clinical Trials Disease 130

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. Download Medidata’s white paper to learn how to virtualize clinical trials and bring new therapies closer to patients. Source link.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Soon after its publication, scientists, journalists, and investors were revisiting ‘phage therapy’ as a promising alternative to our failing antibiotics. Read it on our website here. Illustration by David S. Always free.

Therapies 124

Therapies Virus DNA Clinical Trials 124

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards.

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Predictive Oncology

FEBRUARY 7, 2023

With its technology, the company wants to change the way that biopharma companies plan clinical trials and develop oncology drugs. This is all about getting the right drugs to the right patients at the right time as soon as possible to personalize the treatment of their therapies, primarily in oncology,” said Vennare.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Drug Discovery World

JANUARY 26, 2023

The invasion of Ukraine by Russia was devastating, and its effects were felt throughout pharma as supply chains were disrupted and companies had to pause any operations they were pursuing in those countries, limiting access to medicines in both the near and long term. Despite this, innovation still occurred.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

DrugBank

JUNE 27, 2024

Drug repurposing’s potential to target undruggable molecules is showing huge promise for its ability to accelerate the development of new therapies and improve patient outcomes. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 72

Drugs Pharma Companies Computational Chemistry Clinical Trials 72

Drug Discovery World

JANUARY 24, 2024

Patients experience severe side effects with current medications leading them to discontinue therapy. MT: What technologies are Fibrocor Therapeutics utilising to advance its drug development process? To be successful, biotech companies really need to be ahead of big pharma. You need to set the bar higher.

Small Molecule 148

Small Molecule Research Pharma Companies Disease 148

Drug Discovery World

OCTOBER 7, 2022

Response-mode funding for drug discovery is being administered from the therapeutic division of the organisation for the first time, allowing for strategic build of a fully aligned portfolio stemming from the earliest stages of translational activity. . RA: How can the integration of industry and academia help streamline drug development?

Pharma Companies 130

Pharma Companies Science Research Drug Development 130

Drug Discovery World

NOVEMBER 15, 2022

Synthetic libraries for antibody drug discovery . Developing therapeutic antibodies, one of the most successful approaches in drug development, involves identifying and characterising antibodies to be used as treatment against different types of cancers as well as autoimmune and cardiovascular diseases.

DNA 246

DNA Engineering Drugs Vaccine 246

Drug Discovery World

JULY 19, 2023

The tide has been turning in the worlds of diagnostics and drug development. In the US, the Biden administration has made advancing precision medicine, multi-omics, cell therapies and artificial intelligence-driven drug development all a priority in its 20-year plan.

Science 130

Science Bioinformatics Disease Pharma Companies 130

Drug Target Review

MAY 23, 2023

Therapies developed in recent decades have transformed the treatment of IBD, making hospitalisation and surgery less common. However, many patients respond poorly to corticosteroid treatment, or their immune system responds unfavourably to biological therapies, such as the development of autoimmune diseases.

Small Molecule 75

Small Molecule Drugs Production Pharma Companies 75

Agency IQ

JULY 12, 2024

The examples : 1) a health care provider posting on the internet about unsubstantiated claims that a class of cholesterol drugs causes Alzheimer’s; 2) a celebrity influencer recommending off-label use (i.e., In fact, a “big pharma” company denying the accuracy of a claim may even serve to legitimize that claim in the eyes of some people.

FDA 40

FDA Regulations Production Science 40

Vial

FEBRUARY 19, 2024

From co-founding Acerta Pharma to pioneering patient-centric innovations, Dr. Hamdy shares his impactful career. Explore the groundbreaking VersAptx bioconjugation platform, designed to elevate cancer therapies and uncover the delicate balance between clinical excellence and commercial viability in the dynamic landscape of pharmaceuticals.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

DrugBaron

JULY 19, 2022

Despite the current hype around so called “advanced therapies”, which range from gene editing to cell therapies, and the inexorable advance of biologic therapeutics such as monoclonal antibodies, even in 2022 the majority of drugs in development and reaching patients are still small organic molecules.

Small Molecule 100

Small Molecule Drugs DNA Pharma Companies 100

Drug Discovery World

AUGUST 16, 2022

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Cancer health disparities and underlying contributing factors . Increase representation at all stages .

Research 130

Research Clinical Trials Trials Drug Development 130

The Pharma Data

NOVEMBER 10, 2020

Yohan Tessier, Vice President of Commercial Operations & Strategic Development at Mispro, explained that this is critical in expediting their clients’ time to market. We’re seeing a trend in drug development towards super complex and highly-targeted compounds, which requires researchers to conduct a number of preclinical studies.

Marketing 52

Marketing Pharma Companies Science Research 52

Drug Discovery World

SEPTEMBER 7, 2022

With its use scattered across the industry, just how are researchers utilising AI to improve drug discovery? . Every successful therapy brings with it the necessary supporting data that confirms its efficacy and place on the market. Indeed, the market for AI applications in drug development Is estimated to rise to $5.1

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

The Pharma Data

DECEMBER 30, 2020

It is a strong potential player in the gene therapy space. Its lead candidate is AMT-061, an AAV5-based gene therapy being evaluated for severe and moderately severe hemophilia B in the Phase III HOPE-B study. billion, Regenxbio is also a gene therapy company. UniQure has a market cap of $2.1 With a market cap of $1.6

Vaccine 52

Vaccine FDA Trials Therapies 52